christopher haqq  atara biotherapeutics inc  zoominfocom     bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version christopher m haqq md phd executive profile  biography  bloomberg july    pm et biotechnology company overview of atara biotherapeutics inc snapshotpeople  overviewboard memberscommittees executive profile christopher m haqq md phdexecutive vp of rd and chief scientific officer atara biotherapeutics incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriesas of fiscal year  background dr christopher m haqq also known as chris md phd has been chief scientific officer and executive vice president of rd at atara biotherapeutics inc since september  and served as its chief medical officer since september  dr haqq served as vice president of clinical research  development of cougar biotechnology inc dr haqq has over  years of clinical and translational research experience in oncology dr haqq joined cougar biotechnology inc  in march  and served as its senior director of clinical research and development since may  from  to march  dr haqq was employed by amgen inc where he led the early development oncology group in that role he successfully recruited and managed a team of md and mdphd clinical scientists for amgens phase i and phase ii oncology product candidates he served as an attending urologic oncologist at the ucsf prostate cancer center he was a faculty member in the departments of medicine and urology at the university of california san francisco ucsf he received his md and phd degrees in  from harvard medical school dr haqq completed his residency in internal medicine and fellowships in medical oncology and molecular medicine at ucsfread full background corporate headquarters  gateway boulevardsouth san francisco california united statesphone fax  board members memberships there is no board members memberships data available education bs stanford universityphd harvard medical schoolmd harvard medical school other affiliations stanford universityharvard medical schoolcougar biotechnology inc annual compensation salarybonustotal annual compensation stocks options restricted stock awardsall other compensationexercisable optionsunexercisable optionstotal number of options total compensation total annual cash compensationtotal short term compensationother long term compensationtotal calculated compensation request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact atara biotherapeutics inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft christopher michael haqq  newbury park ca  intelius sign in we found christopher michael haqq in newbury park ca christopher michael haqq intelius found that christopher michael haqq is a male between  and  years old from newbury park ca we have connected them to  addresses  phones and  relatives or associates also known as chris haqq christopher happ get report now age christopher michael haqq is in his s christopher has lived in newbury park ca cambridge ma hialeah fl christophers relatives lynn phung bao phung christopher michael haqq zodiac signsagittarius gendermale professional status materials program manager at intel corporation get report now want to know more about christopher get a comprehensive background report find full phone numbers and other contact information when available all from billions of available public records continue below for more details about christopher or use our people search engine to find others get background check on christopher michael haqq get a criminal check on christopher michael haqq get a public record report on christopher michael haqq get a people search report on christopher michael haqq christopher michael haqqs contact information known cities lived in find out where christopher michael haqq has lived as well as christopher michael haqqs phone numbers and email addresses christopher michael haqq has lived in  states california address for christopher michael haqq  h a newbury park ca has lived in newbury park ca cambridge ma get full address report phone numbers associated with christopher michael haqq    newbury park ca    los angeles ca    santa clara ca get full phone report email addresses associated with christopher michael haqq cqcom cqnet cqedu get email report christopher michael haqqs education information known schools attended learn about christopher michael haqqs academic history find out which schools christopher michael haqq attended the dates attended as well as the degrees christopher michael haqq received the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act christopher michael haqq has attended  schools harvard medical school  –  christopher michael haqq has a md phd in medicine genetics stanford university  –  christopher michael haqq has a bs in biological sciences christopher michael haqqs professional information information regarding christopher michael haqqs professional history find out previous places christopher michael haqq has worked as well as dates employed the following data is not guaranteed for accuracy and should not be used for employment insurance credit eligibility or for any other purpose covered under the fair credit reporting act christopher michael haqq has worked at  places company intel corporation title materials program manager company atara biotherapeutics inc title chief medical officer christopher michael haqqs experience title materials program manager company intel corporation job details company size  bil and above  employee range  and above intel nasdaq intc makes the most amazing experiences of the future possible intels innovations expand the reach and power of computing in personal devices and enterprise servers the cloud make the internet of things smart and connected and help ensure the security of our digital lives the work of the companys more than  employees transforms businesses propels new discoveries and improves human experiences title chief medical officer company atara biotherapeutics inc job details company size  mil to less than  mil  employee range less than  atara biotherapeutics inc is a biopharmaceutical company focused on developing meaningful therapies for patients with unmet medical needs in diseases that have seen limited therapeutic innovation atara bios programs include molecularly targeted product candidates and tcell product candidates molecularly targeted product candidates include pinta  stm  and ata  these product candidates target myostatin and activin members of the tgfbeta family of proteins and have demonstrated the potential to have therapeutic benefit in a number of clinical indications tcell product candidates include ebvctl cmvctl and wtctl additional professional information on christopher michael haqq see christopher michael haqqs linkedin profile christopher michael haqqs social network and potential email matches find out potential social network profiles and potential email usernamed for christopher michael haqq christopher michael haqqs known social networks and potential email matches find all of christopher michael haqqs social network profiles get full report search social networks including facebook linkedin myspace google twitter yahoo jigsaw zoominfo and more potential email matches christopher haqq username matches christopherhaqq haqqchristopher christopherhaqq haqqchristopher christopherhaqq haqqchristopher christopherhaqq haqqchristopher chaqq popular email services gmailcom aolcom yahoocom comcastnet hotmailcom msncom rocketmailcom attnet sbcglobalnet ymailcom facebookcom mailcom bellsouthnet livecom earthlinknet coxnet prodigynet mecom peoplepccom junocom rediffmailcom mindspringcom comcastcom charternet outlookcom all trademarks product names company names or logos on this page are the property of their respective owners related people searches c haqq intelius is a leading provider of public data about people and their connections to others intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fair credit reporting act fcra this site should not be used to determine an individual’s eligibility for credit insurance employment housing or any other purpose covered by the fcra for employment or tenant screening services please visit our partner talentwise about us site map about our reports blog help contact us   –  peopleconnect inc dba intelius all rights reserved privacy policy  updated terms of service  updated what is the fcra the fair credit reporting act fcra is a federal law that promotes the accuracy fairness and privacy of information in the files of consumer reporting agencies intelius does not provide consumer reports and is not a consumer reporting agency as defined by the fcra intelius reports cannot be used for background checks related to consumer credit insurance employment housing or any other purpose prohibited under the fcra you may not use any information obtained from intelius for any purpose covered by the fcra find out more about the fcra here ﻿ christopher haqq atara biotherapeutics inc nasdaqatra’s insider unloaded  shares – octafinance friday  july  menu featured news  years ago  alphabet inc nasdaqgoogl tests its ad technology on billboards to cushion itself against ad blocks  years ago  china margin debt hits week high japan pumps’n’dumps as kyle bass fears looming em banking crisis  years ago  marc faber shares his insight in one hour exclusive interview he covers all from commodities and china to inflation the euro and gold  years ago  carl icahn criticizes the fed feels bad for investors buying junk bonds  years ago  john burbank european qe can’t save the markets same as the us quantitative easing everything will be liquidated christopher haqq atara biotherapeutics inc nasdaqatra’s insider unloaded  shares  by octastaff in insider news share with your friendsyour nameyour emailrecipient emailenter a messagei read this article and found it very interesting thought it might be interesting for you the article is called christopher haqq atara biotherapeutics inc nasdaqatra’s insider unloaded  shares and is was published by octafinancecom at httpwwwoctafinancecomchristopherhaqqatarabiotherapeuticsincnasdaqatrasinsiderunloadedsharescaptchasubmit christopher haqq insider sell transaction stock trade amounting to exactly  us dollars was published in a public form submitted to the security and exchange commission on  according to which christopher haqq the chief medical officer of atara biotherapeutics inc nasdaqatra    also an insider of the company had unloaded precisely  shares –  at  for share  this is not his first insider trade in the last  days he unloaded another  shares worth  usd christopher haqq now owns  shares or  of the company’s total market cap atara biotherapeutics inc stock rating sentiment and fundamentals moreover the analysts of the corporation’s financials indicated a forecast for earningspershare of  according to which atara biotherapeutics inc’s priceearnings ratio would be nan rating  sentimentpsychsignal socialsellanalysts ratingbuyhedge funds sentimentbuy stock fundamentalsearnings  fcf trendsellsectorindustry macrobullishvaluation models technical analysisst trenddownmt trendneutrallt trendup octafinance ratingsell  read how our stock ratings system works the stock price of atara biotherapeutics inc’s has decreased  in just the last  days showing a strong and smooth downtrend our trend model coupled with christopher’s transaction certainly serves to classify this stock as a sell price chart of atara biotherapeutics nasdaqatra stock source rightedgesystems yahoo split  dividend adjusted data and octafinance interpretations as famous stock traders including peter lynch stated best money is made through a combination of fundamental  technical analysis hedge funds ownership recently released f public data filings reveal  institutional investors own shares of atara biotherapeutics inc in q  the firm had  institutional ownership that is a low interest ecor capital llc is the most bullish institutional investor on atara biotherapeutics inc with ownership of  shares as of q  for  of the fund’s portfolio seth klarman’s baupost group llc ma is another bullish asset manager having  million shares of the company or  of their stocks portfolio the stock is also  of the fund’s aum further the new yorkbased fund bridger management llc have  of their stock portfolio invested in the company’s market cap for  shares the californiabased fund redmile group llc disclosed it had purchased a stake worth  of the fund’s stock portfolio in atara biotherapeutics inc the new yorkbased fund visium asset management lp is also very upbeat about the public company owning  shares or  of their stock portfolio atara biotherapeutics nasdaqatra company profile atara biotherapeutics inc is a clinical stage biopharmaceutical company the company is focused on developing therapeutics for serious unmet medical needs with an initial focus on muscle wasting conditions and oncology the company’s lead product candidate pinta  is a peptibody that binds myostatin and inhibits its corresponding signal transduction thereby blocking the negative regulation of skeletal muscle growth pinta  is in a phase ii clinical trial the company’s second product candidate stm  which is in a phase i clinical study is a soluble actrb receptor that binds activin a the company has five additional product candidates ata  a humanized antibody targeting myostatin ata  a fully human antibody targeting activin a ata m a fully human antiactrab monoclonal antibody stm  a soluble actrb receptorigg fc fusion protein and a close analog of stm  and actrb a soluble actrb receptor that can be fused to an igg fc receptor company website atara biotherapeutics atara biotherapeutics inc has  employees currently its market worth is  billion and it has  million outstanding shares today it has  shareholders and the institutional ownership stands at  atara biotherapeutics inc was filled in delaware on  the stock closed at  yesterday and it had average  days volume of  shares it is up from the  days average shares volume of  atara biotherapeutics inc has a w low of  and a one year high of  the stock price is above the  days sma atara biotherapeutics inc last issued its quarterly earnings stats on  the company reported  eps for the quarter missing the consensus estimate of  by  the company had a revenue of for  and for  therefore the revenue was down  transaction pursuant to rule b plan adopted march  –   the price in column  is a weighted average sale price the prices actually received ranged from  to  the reporting person will provide to the issuer – any security holder of the issuer – or the sec staff – upon request – information regarding the number of shares sold at each price within the range  the price in column  is a weighted average sale price the prices actually received ranged from  to  the reporting person will provide to the issuer – any security holder of the issuer – or the sec staff – upon request – information regarding the number of shares sold at each price within the range  the shares are held by the chris haqq  grat – of which the reporting person is trustee receive news  ratings via email  enter your email address below to receive a concise daily summary of the latest news and analysts ratings with marketbeatcoms free daily email newsletter tagged atara biotherapeutics  nasdaqatrachristopher haqq what after kevin weil’s insider sale of twitter inc nysetwtr stock chubb corp nysecb rating decreased at zacks to “hold” free email newsletter enter your email address below to get the latest news and analysts ratings for your stocks with our free daily email newsletter hedge fund newstop  citadel advisors f holdings in q df dent  co inc just released its q  stock positionsmaverick capital top  holdings in q analyzing ken griffins citadel advisors stock holdings in q lone pine capital top  f positions in q guru newsfelix zulauf sees a stock market correction coming this rally sp  indexspinx will be shortlivedmarc faber shares his insight in one hour exclusive interview he covers all from commodities and china to inflation the euro and goldjim grant the next thing might be helicopter money what to buy and where he sees investment opportunitieskyle bass bearish on emerging markets for at least  more years looking to short currenciesdavid tepper gets defensive is it time to get out of the stock market macro newschina margin debt hits week high japan pumps’n’dumps as kyle bass fears looming em banking crisisare us – russian relations a zerosum gameus and russia have launched direct talks on the conflict in syriayuan drops as pboc cuts reference rate by most since devaluationcould the market crash like —put volume spike argues low is nearctas newsred rock just published report about the trend following landscape  how ctas’ performance must be analyzedhow to implement dual momentum for nonus investorsdo commodity trading advisors ctas really provide crisis alpha equity hedge and are long volatility christopher haqq chief medical officer atara biotherapeutics timesjavascript is disabled market profiles login sign up login sign up   edit person christopher haqq chief medical officer at atara biotherapeutics location greater los angeles area add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop christopher haqq chief medical officer at atara biotherapeutics location greater los angeles area add to my lists claim share copy the following code on your pageblog suggested widget size mobile desktop dr christopher haqq joined atara biotherapeutics as chief medical officer in september  he brings  years of clinical academic and drug development experience from biopharma companies large and small he was recently vice president for clinical research and development at cougar biotechnology and johnson  johnston’s janssen where he was the lead clinician for a pivotal prostate cancer study leading to market approval for zytiga® abiraterone acetate previously at amgen he led early development studies of the antiinsulin like growth factor type  receptor amg  ganitumab antibody he has served as medical monitor for more than  clinical trials and has contributed to drug development programs for a wide range of molecules chris has worked closely with the european medicines agency the us food and drug administration and other global regulatory agencies–filing ind applications new drug applications special protocol assessments and their international equivalents earlier in his career chris practiced as a medical oncologist and led a translational science laboratory as an assistant adjunct professor in the division of hematologyoncology at the university of california san francisco in his postgraduate training also at ucsf he served as an intern and resident in internal medicine fellow in medical oncology and fellow in molecular medicine chris completed his md and phd at harvard medical school and his bs at stanford university he is board certified in medical oncology and internal medicine chris is an inventor of three patents and an author of nearly  medical publications in his free time he enjoys astronomy and photography  companies in career na related markets  colleagues na related investments alias na industry pharmaceuticals tags clinical development clinical trials cancer topics of influence na na careers achievements investments related people edit view all christopher haqqcareer   atara biotherapeutics chief medical officer sep to aug genomic systems ceo mar to sep ortho biotech oncology research and development a unit of cougar biotechnology medical oncologist  to  amgen med director  to  ucsf assistant adjunct professor of medicine competencies edit view all christopher haqqeducation   harvard medical school medicine genetics  stanford university biological sciences edit christopher haqqachievements and recognitions add milestone no milestones has been recorded for christopher haqq edit christopher haqqlinks add link no links has been recorded for christopher haqq christopher haqqinvestmentsacquisitions no investments has been recorded for christopher haqq christopher haqqinvestments representing others no investment reps has been recorded for christopher haqq christopher haqqrelated people colleagues at atara biotherapeutics joe newell executive vice president and chief technical operations officer apr david carmel head of immunotherapy mar derrell porter senior vice president and global commercial head jul gad soffer chief operating officer mar view all peers  phil febbo chief medical officer of genomic health shashidhar kori chief medical officer of autonomic technologies vincent miller chief medical officer of foundation medicine neil m barth chief medical officer of veracyte jeff dobro chief medical officer of redbrick health henry dephillips chief medical officer of teladoc view all christopher haqqrecommended market profiles  life sciences kleiner perkins caufield  byers  or more employees  companies healthcare corporate venture deals    employees  companies